Global AI Infrastructure Shift Ignites Biotech Growth Phase
Globe Newswire (Tue, 9-Dec 9:25 AM ET)
Jefferies Sticks to Its Buy Rating for GE Healthcare Technologies Inc (GEHC)
TipRanks (Tue, 9-Dec 8:45 AM ET)
Notable healthcare headlines for the week: UnitedHealth, Eli Lilly, and Bristol Myers in focus
Seeking Alpha News (Sun, 7-Dec 9:05 AM ET)
Barclays Reaffirms Their Hold Rating on GE Healthcare Technologies Inc (GEHC)
TipRanks (Fri, 5-Dec 4:46 AM ET)
Business Wire (Wed, 3-Dec 1:00 PM ET)
Business Wire (Wed, 3-Dec 9:00 AM ET)
Business Wire (Tue, 2-Dec 9:00 AM ET)
Business Wire (Mon, 1-Dec 9:00 AM ET)
GE HealthCare builds on a century of innovation to shape the future of radiology at RSNA 2025
Business Wire (Sun, 30-Nov 10:00 AM ET)
Business Wire (Sun, 30-Nov 9:00 AM ET)
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
Ge Healthcare Techs trades on the NASDAQ stock market under the symbol GEHC.
As of December 10, 2025, GEHC stock price climbed to $84.47 with 2,217,601 million shares trading.
GEHC has a beta of 1.75, meaning it tends to be more sensitive to market movements. GEHC has a correlation of 0.61 to the broad based SPY ETF.
GEHC has a market cap of $38.48 billion. This is considered a Large Cap stock.
Last quarter Ge Healthcare Techs reported $5 billion in Revenue and $1.07 earnings per share. This beat revenue expectation by $68 million and exceeded earnings estimates by $.02.
The top ETF exchange traded funds that GEHC belongs to (by Net Assets): VTI, VOO, QQQ, VO, IVV.
GEHC has underperformed the market in the last year with a return of +3.3%, while SPY returned +14.9%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in GEHC shares. However, GEHC has outperformed the market in the last 3 month and 2 week periods, returning +7.4% and +5.6%, while SPY returned +6.0% and +1.9%, respectively. This indicates GEHC has been having a stronger performance recently.
GEHC support price is $81.43 and resistance is $84.63 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GEHC shares will trade within this expected range on the day.
